View in EDS

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

Saved in:
Bibliographic Details
Title: Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.
Authors: Adams, S1 (AUTHOR) Sylvia.Adams@nyumc.org, Schmid, P2 (AUTHOR), Rugo, H S3 (AUTHOR), Winer, E P4 (AUTHOR), Loirat, D5 (AUTHOR), Awada, A6 (AUTHOR), Cescon, D W7 (AUTHOR), Iwata, H8 (AUTHOR), Campone, M9 (AUTHOR), Nanda, R10 (AUTHOR), Hui, R11 (AUTHOR), Curigliano, G12 (AUTHOR), Toppmeyer, D13 (AUTHOR), O'Shaughnessy, J14 (AUTHOR), Loi, S15 (AUTHOR), Paluch-Shimon, S16 (AUTHOR), Tan, A R17 (AUTHOR), Card, D18 (AUTHOR), Zhao, J18 (AUTHOR), Karantza, V18 (AUTHOR)
Source: Annals of Oncology. Mar2019, Vol. 30 Issue 3, p397-404. 8p. 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy517